Literature DB >> 17393391

Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15.

Mara L Becker1, Tammy M Martin, Trudy M Doyle, Carlos D Rosé.   

Abstract

This is the first report of a CARD15 mutation-positive patient with Blau syndrome who exhibited interstitial lung disease, a feature historically considered absent from Blau syndrome, while typical of the adult form of sarcoidosis. This case illustrates the continued evolution of the phenotype of a disease initially conceived as a familial inflammatory granulomatous disease limited to the triad of synovitis, dermatitis, and uveitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393391     DOI: 10.1002/art.22509

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

Review 1.  The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.

Authors:  Ivan Tattoli; Leonardo H Travassos; Leticia A Carneiro; Joao G Magalhaes; Stephen E Girardin
Journal:  Semin Immunopathol       Date:  2007-08-10       Impact factor: 9.623

2.  NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain.

Authors:  Carlos D Rosé; Juan I Aróstegui; Tammy M Martin; Graciela Espada; Lisabeth Scalzi; Jordi Yagüe; James T Rosenbaum; Consuelo Modesto; Maria Cristina Arnal; Rosa Merino; Julia García-Consuegra; María Antonia Carballo Silva; Carine H Wouters
Journal:  Arthritis Rheum       Date:  2009-06

Review 3.  Distinguishing Blau Syndrome from Systemic Sarcoidosis.

Authors:  Katherine P Kaufman; Mara L Becker
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-09       Impact factor: 4.806

Review 4.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

Review 5.  Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature.

Authors:  Francesco La Torre; Giovanni Lapadula; Luca Cantarini; Orso Maria Lucherini; Florenzo Iannone
Journal:  Clin Rheumatol       Date:  2014-01-21       Impact factor: 2.980

Review 6.  Using genes to triangulate the pathophysiology of granulomatous autoinflammatory disease: NOD2, PLCG2 and LACC1.

Authors:  Ann Marie Szymanski; Michael J Ombrello
Journal:  Int Immunol       Date:  2018-04-25       Impact factor: 4.823

7.  Co-existence of chronic renal failure, renal clear cell carcinoma, and Blau syndrome.

Authors:  Ipek Akil; Aykan Ozguven; Ebru Canda; Omer Yilmaz; Nalan Nese; Mine Ozkol; Sandra May; Andre Franke; Sebahattin Cirak
Journal:  Pediatr Nephrol       Date:  2010-05       Impact factor: 3.714

Review 8.  The spectrum of autoinflammatory diseases: recent bench to bedside observations.

Authors:  John G Ryan; Raphaela Goldbach-Mansky
Journal:  Curr Opin Rheumatol       Date:  2008-01       Impact factor: 5.006

9.  Blau Syndrome and Early-Onset Sarcoidosis: A Six Case Series and Review of the Literature.

Authors:  Ayşenur PaÇ Kisaarslan; Betül SÖzerİ; Nihal Şahİn; Sümeyra Özdemİr ÇİÇek; Zübeyde GÜndÜz; Erkan Demİrkaya; Afig Berdelİ; Serdal Sadet Özcan; Hakan PorazoĞlu; Ruhan DÜŞÜnsel
Journal:  Arch Rheumatol       Date:  2019-11-06       Impact factor: 1.472

10.  NOD2/CARD15 gene mutation identified in a Chinese family with Blau syndrome.

Authors:  Haotian Xiang; Ting Zhang; Mengping Chen; Xiaomin Zhou; Zhen Li; Naihong Yan; Shiguang Li; Yu Han; Qiyong Gong; Xuyang Liu
Journal:  Mol Vis       Date:  2012-03-09       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.